Riley Macdonald joined Frist Cressey Ventures in 2018. Prior to FCV, Mr. Macdonald worked as a Senior Analyst on the Strategic Planning team at Intermedix, where he supported board-level strategic initiatives including the $460m sale of the company by Thomas H. Lee Partners to R1 RCM. Mr. Macdonald started his career as an Investment Banking Analyst in the Healthcare Group at KeyBanc Capital Markets.
Mr. Macdonald graduated from Vanderbilt University with a B.A. in Economics with a minor in Corporate Strategy.